⚙

Pathophysiology Nodes

3
3 shared nodes are defined in this module.
◉

Cell Types

0
No cell types are annotated for this module.
⇄

Biological Processes

3
D-Glucose Transmembrane Transport GO:1904659 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased D-Glucose Transmembrane Transport (GO:1904659). GO:1904659 is a biological process from the Gene Ontology. Glycolytic Process GO:0006096 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Glycolytic Process (GO:0006096). GO:0006096 is a biological process from the Gene Ontology. Glucose Metabolic Process GO:0006006 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Glucose Metabolic Process (GO:0006006). GO:0006006 is a biological process from the Gene Ontology.
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "deregulated_cellular_energetics#Aerobic Glycolysis (Warburg Effect)"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding biological processes and causal edges, specialized to their tumor context. Key tumor-specific substitutions: MYC/PI3K-AKT-driven tumors show glucose and glutamine addiction; IDH-mutant gliomas/AML produce the oncometabolite 2-hydroxyglutarate that reprograms the epigenome; VHL-deficient renal cell carcinoma uses HIF-driven glycolysis. Key conformance target: "deregulated_cellular_energetics#Aerobic Glycolysis (Warburg Effect)".
⌘

Module Collections

1
↗

Used By Disorder Entries

5
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Deregulating Cellular Energetics Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

3
Oncogene-Driven Nutrient Uptake
trigger
Normal cells take up nutrients only when stimulated by growth factors; cancer cells acquire mutations that constitutively activate nutrient-uptake and metabolic signaling (PI3K-AKT-mTOR, MYC, RAS), upregulating glucose transporters (GLUT1) and amino-acid transporters. This cell-autonomous, growth-factor-independent nutrient acquisition is the metabolic entry point of the hallmark.
D-Glucose Transmembrane Transport GO:1904659 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased D-Glucose Transmembrane Transport (GO:1904659). GO:1904659 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:26771115 SUPPORT Other
"A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass."
Establishes deregulated nutrient acquisition as a common feature of cancer metabolism, the trigger of this module. Evidence source is OTHER because this is a review article.
Aerobic Glycolysis (Warburg Effect)
central effector
Cancer cells preferentially metabolize glucose to lactate even in the presence of oxygen sufficient for oxidative phosphorylation - the Warburg effect. Though inefficient in ATP yield per glucose, high glycolytic flux rapidly regenerates ATP and, critically, supplies carbon intermediates for biosynthesis. This is the conserved central node of the metabolic hallmark; it does not require defective mitochondria.
Glycolytic Process GO:0006096 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Glycolytic Process (GO:0006096). GO:0006096 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:19460998 SUPPORT Other
"most cancer cells produce large amounts of lactate regardless of the availability of oxygen"
Directly describes aerobic glycolysis (lactate production despite adequate oxygen), the central effector of this module. Evidence source is OTHER because this is a review article.
PMID:21376230 SUPPORT Other
"reprogramming of energy metabolism and evading immune destruction"
Hanahan & Weinberg name reprogramming of energy metabolism as an emerging hallmark, the capability modeled here. Evidence source is OTHER because this is a review article.
Biosynthetic Diversion for Biomass Production
consequence
Glycolytic and TCA-cycle intermediates are diverted into anabolic pathways: glucose-6-phosphate into the pentose phosphate pathway for ribose and NADPH, 3-phosphoglycerate into serine/glycine and one-carbon metabolism, citrate into fatty-acid synthesis, and glutamine into anaplerosis and nitrogen for nucleotide/amino-acid synthesis. This diversion converts nutrients into the macromolecular building blocks (nucleotides, amino acids, lipids) required to produce a new cell, the biosynthetic purpose of the Warburg phenotype.
Glucose Metabolic Process GO:0006006 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Glucose Metabolic Process (GO:0006006). GO:0006006 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:19460998 SUPPORT Other
"most cancer cells instead rely on aerobic glycolysis"
Supports the reliance on aerobic glycolysis whose biosynthetic role (channeling nutrients into biomass) is modeled in this consequence node. Evidence source is OTHER because this is a review article.